SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma

Journal:

Cancer Research

Published:

2025-07-01

DOI:

10.1158/0008-5472.can-24-2745

Affiliations:

8

Authors:

14

Go to article

Institutions	Authors	Share
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)	7.000000	0.50
Caris Life Sciences, United States of America (USA)	3.000000	0.21
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)	2.000000	0.14
Montefiore Medical Center, Einstein, United States of America (USA)	1.000000	0.07
Milton S. Hershey Medical Center, Penn State, United States of America (USA)	1.000000	0.07

Interested in Medical Biochemistry and Metabolomics?